- Open Access
Mouse Cytomegalovirus infection overrules T regulatory cell suppression on natural killer cells
Virology Journal volume 11, Article number: 145 (2014)
Cytomegalovirus establishes lifelong persistency in the host and leads to life threatening situations in immunocompromised patients. FoxP3+ T regulatory cells (Tregs) critically control and suppress innate and adaptive immune responses. However, their specific role during MCMV infection, especially pertaining to their interaction with NK cells, remains incompletely defined.
To understand the contribution of Tregs on NK cell function during acute MCMV infection, we infected Treg depleted and undepleted DEREG mice with WT MCMV and examined Treg and NK cell frequency, number, activation and effector function in vivo.
Our results reveal an increased frequency of activated Tregs within the CD4+ T cell population shortly after MCMV infection. Specific depletion of Tregs in DEREG mice under homeostatic conditions leads to an increase in NK cell number as well as to a higher activation status of these cells as compared with non-depleted controls. Interestingly, upon infection this effect on NK cells is completely neutralized in terms of cell frequency, CD69 expression and functionality with respect to IFN-γ production. Furthermore, composition of the NK cell population with regard to Ly49H expression remains unchanged. In contrast, absence of Tregs still boosts the general T cell response upon infection to a level comparable to the enhanced activation seen in uninfected mice. CD4+ T cells especially benefit from Treg depletion exhibiting a two-fold increase of CD69+ cells 40 h and IFN-γ+ cells 7 days p.i. while, MCMV infection per se induces robust CD8+ T cell activation which is also further augmented in Treg-depleted mice. Nevertheless, the viral burden in the liver and spleen remain unaltered upon Treg ablation during the course of infection.
Thus, MCMV infection abolishes Treg suppressing effects on NK cells whereas T cells benefit from their absence during acute infection. This study provides novel information in understanding the collaborative interaction between NK cells and Tregs during a viral infection and provides further knowledge that could be adopted in therapeutic setups to improve current treatment of organ transplant patients where modulation of Tregs is envisioned as a strategy to overcome transplant rejection.
Mouse cytomegalovirus (MCMV) belongs to the family of β-herpes viruses and shares many attributes with human cytomegalovirus (HCMV). This makes it an attractive tool to study CMV associated immune responses in an infection model to better characterize the CMV-host relationship in vivo. CMV reactivation and primary infection pose as a major health concern in transplantation medicine leading to life threatening consequences in immunocompromised patients. As a means of suppressing transplant rejections in patients, one novel proposed strategy has been to adoptively transfer ex vivo expanded FoxP3+ T regulatory cells (Tregs) . In order to better understand their role in acute CMV infection, this study sets out to elucidate their interaction with NK cells and effector T cells using an MCMV mouse model. Natural Tregs are major players in suppressing the immune system and are therefore important for controlling the balance between activation and tolerance [2, 3]. The transcription factor FoxP3 is a specific regulatory gene that distinguishes Tregs from other cell types and is important for their suppressive function . A frameshift mutation in the FoxP3 gene locus on the X-chromosome in Scurfy mice results in a lethal multi-organ inflammation caused by a massive proliferation of effector T cells . Despite the fact that Tregs are crucial for maintenance of the immune homeostasis, they are also known to suppress the immune system in several diseased conditions like cancer  or in the context of infections for example induced by viruses [7–13]. In doing so, they dampen pathogen-specific innate or adaptive immune responses and impede pathogen clearance from the host in most infectious settings. Treg suppression spans a diverse cohort of immune cells including monocytes, dendritic cells (DCs), NK cells, NKT cells, CD4+ and CD8+ effector T cells [14, 15]. They conduct their suppression using an arsenal of mechanisms such as modulating the bioavailability of IL-2 [16, 17], production of certain cytokines like IL-10, IL-35, TGF-β and signaling molecules like cAMP , direct killing  or downregulating co-stimulatory molecules CD80/86 on DCs via CTLA-4 by trans-endocytosis  and thereby indirectly suppress T effector responses. During acute MCMV infection, NK cells predominantly confer resistance against MCMV-induced pathogenesis by recognizing the viral m157 glycoprotein on infected cells via the Ly49H receptor [21–23]. Thus, mouse strains exhibiting NK cells equipped with this receptor like C57BL/6 are far more resistant than strains lacking it like BALB/c. According to Dokun et al [24, 25], the NK response to MCMV constitutes three phases. The first phase consists of an unspecific proliferation of NK cells with no preferential expansion of the Ly49H+-MCMV specific subset, which is postulated to be mostly cytokine dependent, followed by an MCMV-specific expansion and subsequent outgrowth of Ly49H+ cells within the NK cell population. In contrast to other Ly49 receptors, Ly49H associates with immunoreceptor tyrosine-based activation motifs (ITAMs) on the adaptor molecules DAP10 and DAP12, which are responsible for inducing proliferation and activation [22, 26]. The final phase consists of a slow contraction of the total NK cell response and frequency until baseline levels are achieved [24, 27].
Studies carried out by Ghiringhelli et al., demonstrated that mutant Scurfy mice lacking the functional gene FoxP3 exhibited, in addition to highly activated T effector cells, a 10 fold greater NK cell proliferation . Furthermore, enhanced cytotoxicity of NK cells was observed as compared with WT mice with no added influence on their activation state. In vitro studies as well as tumor mouse models provided evidence that a direct control of Tregs on NK cells may exist and results in impaired functionality of NK cells in the presence of Tregs [28–30]. Membrane-bound Transforming growth factor beta was proposed to be involved in this process, since blocking antibodies of this complex abolished the observed effects . Recent studies by Gasteiger et al. showed an indirect interaction mediated by increased IL-2 levels produced by CD4+ T cells upon Treg depletion [31, 32]. IL-2 signaling on NK cells induced proliferation and additionally enhanced their cytotoxic function via increased sensitivity for target cells.
These observations led us to ask the question whether this interaction between NK cells and Tregs is also of importance in a viral model like MCMV, where NK cell proliferation is initially cytokine dependent and later driven by signaling of the NK cell-activating receptor Ly49H.
Here, we show that boosting effects of Treg depletion on NK cells under homeostatic conditions are overruled upon MCMV infection with no preferential effects on Ly49H subsets. The viral clearance remains unchanged even though we observe enhanced general T cell activation, highlighting the outstanding role of NK cells in controlling MCMV infection in C57BL/6 mice. These results clearly indicate that the role of Treg-mediated suppression on NK cells activated by MCMV infection is at best negligible, whereas the activation of T cells is further enhanced in the absence of Tregs.
MCMV infection leads to elevated FoxP3+ Tregs in the CD4+ T cell compartment
Cytomegalovirus has developed a number of immune-evasion mechanisms to prolong its survival within the host [33, 34]. As Tregs display certain features to be a possible target of immune evasion mechanisms, we set out to characterize in detail the effect of MCMV on Treg properties during the course of acute infection. We first examined the Treg response initiated by MCMV infection in the spleen as a site for primary MCMV replication. We observed a significant increase in the frequency of these cells among CD4+ T cells from 40 hours post infection (h p.i.) (Figure 1B) with a similar increase in the absolute number of Tregs (Additional file 1: Figure S1). This increase in Tregs persisted even at day 3 p.i. when compared with mock-infected mice (Figure 1E) and is irrespective of DT treatment (Additional file 1: Figure S1D). Furthermore, a larger proportion of infection-induced Tregs showed a higher activation state indicated by increased early activation marker CD69 expression after 40 h (Figure 1C) and 3 days p.i. (Figure 1F). This increase was evident even by the mean fluorescence intensity (MFI) of CD25 40 h p.i. (Figure 1D) and on day 3 p.i. (Figure 1G). On day 7 p.i., representing the peak phase of the T cell response to MCMV with regard to non-inflationary T cell epitopes [35, 36], FoxP3+ cells were significantly reduced amongst the CD4+ T cell population (Figure 1H) but still showed an increased MFI of CD25 (Figure 1I) and of CTLA-4 (Figure 1J). Hence, we hypothesized that depletion of FoxP3+ cells may result in an enhanced anti-viral immune response. To investigate the influence of Tregs during the acute phase of the infection, we used DEREG mice, allowing for selective depletion of FoxP3+ Tregs by Diphtheria toxin (DT) administration . Our data demonstrates that DT treatment on day 0 and day 1 p.i. (Figure 1A) results in efficient depletion of Tregs in our infection model at all time points of analysis (Figure 1B, E and H). The efficiency of the depletion is depicted in Additional file 2: Figure S2B and is also represented in the total number of Tregs (Additional file 1: Figure S1A, B and C). Even though Treg frequencies reached WT levels by day 7 after the first DT injection under homeostatic conditions, they remained significantly lower in infected Treg-depleted mice (Figure 1H and Additional file 2: Figure S2B). Hence, we determined that DEREG mice serve as an efficient tool for investigating acute MCMV disease progression in the absence of Tregs.
Depletion of Tregs enhances NK cell frequency, number and activation state under homeostatic conditions with no added influence upon MCMV infection
NK cells are important cellular mediators of the immune response needed to control MCMV infection. Previous studies have demonstrated that Scurfy mice bear functionally impaired Tregs  and therefore show higher numbers of activated NK cells . To better elucidate the relationship between Tregs and NK cells, we investigated the effect of Treg depletion on NK cells during acute MCMV infection. We found that under homeostatic conditions, DEREG mice that were depleted of Tregs showed significantly higher frequencies of NK cells with comparable NK cell number after 40 h p.i. (Figure 2A and B) but this effect of depletion on NK cells was even more pronounced at day 3 p.i. (Figure 2D) and was reflected in the frequency and the total number of NK cells per spleen at this time point (Figure 2E). The increase in NK cells correlated with Treg depletion as on day 7 p.i., when Tregs reached wild type levels in mock infected mice, no differences in NK cell frequency and number were detectable between the two groups (Figure 2H). Surprisingly, the NK cell boosting effect of Treg depletion is completely abolished upon MCMV infection. No increase in NK cell frequency was observed in infected mice (Figure 2A and D), while activation state assessed by CD69 expression (Figure 2C and F) or maturation determined by KLRG-1 expression (Figure 2G and I) did not differ in the whole NK cell population as well as in the Ly49H+ NK cell compartment (Figure 2I and Additional file 3: Figure S3A, B). Furthermore, infection failed to alter the frequency and number of Ly49H+ NK cells even at a late time-point of day 7 p.i.. Although we detected a notable increase in CD69 expression upon DT treatment of DEREG mice, under homeostatic conditions after 40 h, 3 days and 7 days p.i. (Figure 2C, F and Additional file 3: Figure S3B), analysis of the maturation state of Ly49H+ versus Ly49H- NK cells revealed an unaltered composition of MCMV-specific versus unspecific NK cells in uninfected as well as infected mice (Figure 2G and I) although infection increased KLRG1 expression irrespective of Treg depletion compared to uninfected mice (Infected ≥ 60% of NK cells versus uninfected ≤40% of NK cells) (Figure 2I). These findings suggest that Treg depletion fails to favor an outgrowth of either of the two NK cell subsets neither is the maturation altered. Hence, simultaneous ablation of Tregs and MCMV infection does not enhance the number or alter the phenotype of NK cells in contrast to steady state depletion.
Interferon-γ production of NK cells in response to MCMV is not further enhanced in the absence of Tregs
During the acute phase of MCMV infection Interferon-γ (IFN-γ) proves indispensable for effective MCMV control with NK cells being the main producers early after infection. Aside from granzymes and perforin, IFN-γ production constitutes one of the most important counteractive measures by NK cells against viral propagation [38–41]. Therefore, to test for functional consequences of Treg depletion on NK cells, we performed intracellular FACS staining of IFN-γ after a 4-hour restimulation with IL-2 in the presence of Brefeldin A. Using this protocol, modified from Mitrovic et al. , we could demonstrate that about 25% of NK cells from infected animals expressed IFN-γ (Figure 3A and B) as compared with mock- infected WT DT-treated animals after 40 h p.i. which showed a minor unspecific proportion of IFN-γ+ NK cells accounting for ≈ 2% of NK cells. However, quantification of the frequency of the IFN-γ+ NK cells revealed no differences between DEREG MCMV + DT-treated and WT MCMV + DT-treated mice, neither at the peak phase of IFN-γ production of NK cells, at 40 h p.i., nor at day 3 p.i. (Figure 3B and C). Fogel et al. reported a correlation between CD69 expression and IFN-γ production of NK cells . Interestingly, although we observed a minor increase in CD69 expression on NK cells at these time points upon Treg depletion under naïve conditions, the increase in activation did not reflect the ability to produce IFN-γ as DEREG DT-treated mice showed comparably low frequencies of IFN-γ+ NK cells as WT DT-treated mice. Analysis of the Ly49H sub-compartments again showed no preferential effect of Treg depletion on either population (Figure 3A and data not shown). To rule out any biasing effects of IL-2 ex vivo restimulation, we performed additionally a PMA/Ionomycin restimulation assay on NK cells which revealed the same results but showed higher activation in general (Additional file 3: Figure S3C).
Viral burden remains unaltered upon ablation of Tregs
In order to examine the contribution of Treg depletion to viral clearance, we measured the viral load in the infected-depleted mice versus infected-non-depleted ones at different days p.i. Our results showed equally high viral loads in spleen and liver from both experimental mouse groups over the course of infection (Figure 4A and B). On day 7 p.i., viral burden was close to the detection limit in these organs and not detectable in the salivary glands (data not shown) of DEREG MCMV + DT-treated mice as well as WT MCMV + DT-treated ones, with no added differences upon Treg depletion. Overall, we show that viral clearance in immunocompetent DEREG mice, on C57BL/6 genetic background, is independent of Treg mediated function.
Ablation of Tregs results in a boosted general T cell response
The unaltered viral load in spleen and liver raised questions about the influence of Treg depletion on the adaptive T cell response upon MCMV infection and its impact on viral clearance. DEREG MCMV + DT-treated mice showed an early and significant increase in activated T cells assessed by CD69 expression in both the CD8+ as well as more pronounced, in the CD4+ compartment after 40 h p.i. as compared with WT MCMV + DT-treated mice (Figure 5A and B). Since day 7 p.i., represents the peak phase of T cell expansion and activation with regard to non-inflationary T cell epitopes upon MCMV infection, we examined the influence of Treg depletion at this time point and observed that general T cell responses are indeed enhanced. Overall, the frequency of T cells among splenic cells is increased with a simultaneous and significant increase in the ratio of CD8+ to CD4+ T cells in infected, Treg-depleted mice (Figure 5C). Furthermore up to 90% of CD8+ T cells and 70% of CD4+ T cells expressed low mean fluorescence intensity for CD62L as compared with 65% and 45% respectively in WT MCMV infected animals (Figure 5D and E). Strikingly, MCMV infection induced KLRG-1 expression in half of all CD8+ T cells, while infection plus Treg depletion further enhanced the maturation indicated by an increase of up to 80% of KLRG-1+ cells among CD8+ T cells (Figure 5F). In contrast to the influence on NK cells, the absence of Tregs also leads to higher frequencies of T cells responding with enhanced IFN-γ production in response to ex vivo restimulation (Figure 5G and H). Furthermore, the frequency of IFN-γ+CD4+ T cells increased two-fold in DEREG mice that were infected and DT treated. Overall, we show that Treg depletion and infection strongly promotes the expansion, activation and maturation of effector CD4+ and CD8+ T cells with simultaneous increases in IFN-γ production by both subsets.
CMV is a medically important DNA virus with high pathogenesis in immunocompromised and newborn individuals, representing a major reason for organ rejection in transplanted patients. Although anti-viral therapies to treat CMV disease are employed in the clinics, treatment is associated with poor oral bioavailability, development of anti-viral drug resistance over time and anti-viral drug related cytotoxicities . Hence, there remains an urgent need to develop new anti-CMV compounds with different mechanism of action to reduce morbidity and contain infection. Thus, targeting Tregs has been suggested as a potential cell mediated approach for immunotherapy against infections .
A number of studies examining this concept, demonstrated the contribution of Tregs in promoting suppression of pathogen specific effector responses [7–10, 45–48], while others showed beneficial effects of Tregs upon infections [12, 49–52]. In this study, we set out to primarily examine the role of Tregs in modulating the MCMV-specific NK cell responses during the acute phase of infection, which until now remained incompletely defined. We observed elevated Treg frequencies among CD4+ T cells in the spleen early upon infection, indicating that MCMV infection may preferentially support differentiation of naïve T cells into Tregs, similarly described in a hepatitis virus infection model  where TGF-β induced by infection controlled this phenotypic change. To specifically address the question of whether the increase in Tregs influences the ongoing activation of innate and adaptive immune responses, we utilized DEREG mice to facilitate specific Treg depletion by Diphtheria toxin (DT) administration . The advantage of the rapid and efficient depletion of Tregs in our model provided us the opportunity to infect mice on the day of first DT injection to really assess the influence of Tregs on NK cells during virus replication and thus minimize effects occurring prior to the onset of infection. This fact could account for the contrasting results Sungur et al. reported in terms of enhanced viral clearance upon CD25 antibody-mediated Treg depletion starting 2 days before infection . In respect to these findings, we observed that under homeostatic conditions, depletion of Tregs significantly increased NK cell numbers and NK cell CD69 expression. Thus, depletion prior to infection could contribute to this discrepancy between both studies by conferring enhanced anti-viral defense already before infection. As Tregs return to baseline levels by day 7 p.i. in uninfected mice, our experimental mouse model avoids the development of artificial autoimmunity  and hence provides an unbiased approach to examine the phenotypes observed here upon infection. To further elucidate the interaction of Tregs with NK cells, and its influence on control of MCMV replication in C57BL/6 mice, we examined NK cell numbers and activation in the absence of Tregs. We detected elevated NK cell frequencies in uninfected DEREG mice depleted of Tregs consistent with findings reported in Scurfy mice and FoxP3 DTR knock-in mice [28, 32]. These cells additionally showed notably higher CD69 expression. In contrast, upon infection, we observed comparable NK cell responses between Treg-depleted and non-depleted mice. Studies by Fulton et al. and Lee et al. reported concordantly increased NK cell numbers in the lungs of Respiratory Syncytial Virus infected-BALB/c mice upon Treg depletion, which was carried out again by CD25 antibody administration starting already 3 days prior to infection [56, 57]. Using uninfected FoxP3 DTR knock-in mice, Gasteiger et al. pointed out that the increase of NK cell numbers upon Treg depletion corresponds to elevated CD127+ NK cell frequencies, expressing higher amounts of high affinity IL-2 receptor CD25 . Therefore, enhanced IL-2 production by effector CD4+ T cells in the absence of Tregs may represent the likely mechanism underlying this phenomenon. This hypothesis was further substantiated by experiments that showed abrogation of this effect by blocking the IL-2 pathway or depleting the CD4+ T cell compartment  and similarly reported by Sitrin et al. in an autoimmune diabetes mouse model . Our results in uninfected mice corroborate these findings as we similarly detected higher activation of CD4+ T cells upon Treg depletion. Although we observed a boosted CD4+ as well as CD8+ T cell response in DEREG MCMV + DT-treated mice as compared with WT MCMV + DT-treated mice, we could not detect differences in NK cell frequencies in infected mice suggesting that this proposed mechanism will need further clarification under a more infectious setting such as a salivary gland infection, where the demand for Ly49H+ NK cells would be further exemplified. A possible reason for this discrepancy could be that NK cells already achieve maximal proliferation upon tissue cultured MCMV infection and thus, fail to benefit from Treg depletion or elevated IL-2 levels. Treg depletion in MCMV-infected mice leads to higher proliferation of effector T cells, predominantly CD8+ T cells which represent the majority of T cells at day 7 p.i. Thus, consumption of IL-2 by proliferating CD8+ T cells which is not seen upon Treg depletion under homeostatic conditions, may offer another potential explanation. Treg ablation leads to similar frequencies of CD62low CD4+ T cells as compared with those induced by MCMV infection alone. However, CD8+ T cells are significantly more activated upon MCMV infection than upon Treg depletion of naive mice and thus could abrogate IL-2 mediated effects. The insensitivity of the viral clearance to a boosted T cell response highlighted the importance of NK cells in limiting WT MCMV replication in C57BL/6 mice emphasized by a rapid clearance until day 7. The implications of Treg control over effector CD8+ T cell response would prove critical if the Ly49H receptor engagement was somehow abrogated as observed in the case of mice challenged with Δm157-strain of MCMV, where CD8+ effector T cells critically governed the outcome of viral replication in infected organs . In Ly49H+ NK cell competent C57BL/6 mice, we observed an initial viral burden that was already 100-fold reduced and close to the detection limit when the T cell response peaked. Our findings provide further support to the multi-functional importance of NK cells spanning the innate and adaptive arms of the immune system [59–61]. Furthermore, since MCMV infection primarily induces stronger CD8+ T cell responses, the contribution of the enhanced CD4+ T cell activation we observe upon infection in Treg depleted mice would require further investigation. CD4+ T cells are key players in establishing immunological memory and moreover known to develop cytotoxic abilities to directly attack infected cells under certain circumstances [62–64]. This makes them an important factor during MCMV infection and their importance may be further enhanced upon their suppression by Tregs. Thus, our results provide new evidence that Tregs play a role in modulating the immune response to MCMV infection, but this effect seems to be restricted to the suppression of adaptive immune cell activation. Our results suggest that Tregs enhance the general effector T cell response while NK cell function remains unaltered. This expansion in the CD8 T cell pool would warrant for further investigation into the contribution of Treg depletion on the antigen-specific effector T cell compartment after infection. The importance of Treg regulation on CD8 T cells in the absence of Ly49H-NK cell recognition has been recently analyzed in an independent study described by us in collaboration with Hansen and colleagues, showing enhanced activation, cytotoxicity and improved viral clearance in DEREG Balb/c mice depleted of Tregs . Thereby, suggesting an important regulatory role by which NK-Ly49H function in concert with Tregs modulate anti-MCMV T cell effector responses . This could be further extended into infection models in C57BL/6 mice employing a Δm157 MCMV strain, where the requirement for antigen specific T cells in viral clearance is further exemplified. Overall, our findings provide a foundation for the development of future Treg-mediated therapeutics in viral infections and in a broader context, in Treg-modulating strategies to overcome transplant rejection.
Materials and methods
Previously described DEREG mice on C57BL/6 background were used, allowing for the efficient and selective depletion of FoxP3+ T regulatory cells by the administration of Diphtheria toxin (DT) . DT was administered in the amount of 25 ng/g bodyweight on both the day of infection and the following one. Male DEREG mice aged 8-12 weeks were used for experiments and gender- and aged-matched WT littermates served as controls. Mice were housed under specific pathogen free conditions at the animal facility of Twincore (Hannover, Germany). The protocol for this research study involving mice was approved by a suitably constituted Ethics Committee of the institution and was performed in accordance with animal welfare guidelines approved by institutional, state, and federal committees. Mice were sacrificed by CO2 asphyxiation in accordance with German animal welfare law. Every effort was made to minimize animal suffering.
For infection, BAC derived MCMV WT Smith strain was used , which was kindly provided by Martin Messerle (Institute of Virology, Hannover Medical School, Germany). Virus propagation was carried out on doxycycline induced murine embryonic fibroblasts, also kindly provided by Dr. Tobias May from the Helmholtz Center for Infection Research and InSCREENeX (Braunschweig, Germany) . Mice were infected with 106 pfu of tissue cultured-derived virus by the intraperitoneal route.
Viral titers were determined by plaque assay performed on mouse embryonic fibroblasts (MEFs) as previously described . Spleens and livers were frozen with 0.5 ml DMEM medium and after brief thawing homogenized using a TissueLyserLT (Qiagen) (50 Hz, 2:30 min). Ten-fold dilutions were prepared in duplicates and sub-confluent MEF layers were inoculated with homogenates for 2 h at 37°C. Following incubation, the inoculum was removed and cells were overlayed with 0.75% (w/v) carboxymethylcellulose (Sigma) in growth medium for each well. Plaques were counted after 6-8 days.
Red blood cells in single-cell suspensions of spleens were lysed using RBC lysis buffer (150 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA). The isolated cells were counted by Trypan Blue exclusion and adjusted to the same cell number for FACS staining. After washing with PBS, cells were stained with the LIVE/DEAD® Fixable Aqua Dead Cell Stain Kit (Invitrogen, Life Technologies GmbH, Darmstadt, Germany) to exclude dead cells. Following incubation with FACS buffer (0.25% BSA/ 2 mM EDTA in PBS) containing Fc-block (CD16/32, 2.4G2) for 10 min on ice cells were stained for surface markers with the following fluorochrome conjugated anti-mouse antibodies for 20 to 30 min on ice:
CD3 (145-2C11), CD4 (GK1.5), CD8α (53-6.7), CD25 (PC61.5), CD62L (MEL-14), CD69 (H1.2 F3), KLRG-1 (2 F1), Ly49H (3D10), NK1.1 (PK136).
Cells were fixed by using the Foxp3/Transcription Factor Staining Buffer Set (eBioscience, affymetrix, Frankfurt, Germany). Anti-mouse FoxP3 antibody FJK-16 s and anti-mouse CTLA-4 antibody UC10-4B9 (BioLegend, London, United Kingdom) were used for intracellular staining.
Unless otherwise stated, all antibodies were purchased from eBioscience, affymetrix (Frankfurt, Germany). Samples acquisition was performed on an LSRII Flow cytometer (BD Bioscience GmbH, Heidelberg, Germany), with the results analyzed using FlowJo software (Tree Star, Inc. Ashland, USA). Accurate gating was confirmed by single stains and fluorescence minus one controls, with non-specific binding was estimated by isotype controls. Cellular aggregates were excluded by SSC-W.
Ex vivo stimulation assays
NK cell production of Interferon- γ (IFN-γ) was assessed by IL-2 re-stimulation in a 96-well U bottom plate. Splenocytes in the amount of 3×106 were incubated with 250 U/ml IL-2 for 2 h initially, followed by an additional 2 h in the presence of 3 μg/ml BrefeldinA with 125 U/ml. For T cell ex vivo stimulation 25 ng/ml Phorbol-12-myristate-13-acetate (PMA) and 250 ng/ml Ionomycin were used for 4 h in the presence of 3 μg/ml BrefeldinA. Cells were stained for surface markers as described under Flow Cytometry. Intracellular staining for IFN-γ was performed after fixation in 2% PFA in PBS for 20 min on ice and permeabilization in PBS containing 0.25% BSA, 2 mM EDTA, and 0.5% saponin. PE conjugated anti-mouse IFN-γ antibody clone XMG1.2 (eBioscience, affymetrix, Frankfurt, Germany) was used.
Two-tailed, unpaired Student’s t-test was used to calculate the statistical significance of differences between means of groups or samples. A p-value <0.05 was considered significant, as indicated by asterisk signs: (*) for P < 0.05, (**) for P < 0.01 and (***) for P < 0.001.
Killer cell lectin-like receptor G1
FoxP3+ T regulatory cell.
Schliesser U, Streitz M, Sawitzki B: Tregs: application for solid-organ transplantation. Curr Opin Organ Transplant 2012, 17: 34-41.
Berod L, Puttur F, Huehn J, Sparwasser T: Tregs in infection and vaccinology: heroes or traitors? Microb Biotechnol 2012, 5: 260-269.
Mayer CT, Berod L, Sparwasser T: Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity. Front Immunol 2012, 3: 183.
Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4: 330-336.
Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, Hamann A, Wagner H, Huehn J, Sparwasser T: Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 2007, 204: 57-63.
Klages K, Mayer CT, Lahl K, Loddenkemper C, Teng MW, Ngiow SF, Smyth MJ, Hamann A, Huehn J, Sparwasser T: Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma. Cancer Res 2010, 70: 7788-7799.
Fernandez MA, Puttur FK, Wang YM, Howden W, Alexander SI, Jones CA: T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice. J Immunol 2008, 180: 1556-1564.
Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT: CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 2004, 172: 4123-4132.
Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT: CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 2003, 198: 889-901.
Belkaid Y, Rouse BT: Natural regulatory T cells in infectious disease. Nat Immunol 2005, 6: 353-360.
Iwashiro M, Messer RJ, Peterson KE, Stromnes IM, Sugie T, Hasenkrug KJ: Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc Natl Acad Sci U S A 2001, 98: 9226-9230.
Lund JM, Hsing L, Pham TT, Rudensky AY: Coordination of early protective immunity to viral infection by regulatory T cells. Science 2008, 320: 1220-1224.
Zelinskyy G, Dietze K, Sparwasser T, Dittmer U: Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirus. PLoS Pathog 2009, 5: e1000406.
Ralainirina N, Poli A, Michel T, Poos L, Andres E, Hentges F, Zimmer J: Control of NK cell functions by CD4+CD25+ regulatory T cells. J Leukoc Biol 2007, 81: 144-153.
Schmidt A, Oberle N, Krammer PH: Molecular mechanisms of treg-mediated T cell suppression. Front Immunol 2012, 3: 51.
Kastenmuller W, Gasteiger G, Subramanian N, Sparwasser T, Busch DH, Belkaid Y, Drexler I, Germain RN: Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J Immunol 2011, 187: 3186-3197.
McNally A, Hill GR, Sparwasser T, Thomas R, Steptoe RJ: CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis. Proc Natl Acad Sci U S A 2011, 108: 7529-7534.
Bodor J, Bopp T, Vaeth M, Klein M, Serfling E, Hunig T, Becker C, Schild H, Schmitt E: Cyclic AMP underpins suppression by regulatory T cells. Eur J Immunol 2012, 42: 1375-1384.
Josefowicz SZ, Lu LF, Rudensky AY: Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012, 30: 531-564.
Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, Baker J, Jeffery LE, Kaur S, Briggs Z, Hou TZ, Futter CE, Anderson G, Walker LS, Sansom DM: Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 2011, 332: 600-603.
Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, Iizuka K, Furukawa H, Beckman DL, Pingel JT, Scalzo AA, Fremont DH, Yokoyama WM: Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 2002, 99: 8826-8831.
Orr MT, Sun JC, Hesslein DG, Arase H, Phillips JH, Takai T, Lanier LL: Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection. J Exp Med 2009, 206: 807-817.
Scalzo AA, Corbett AJ, Rawlinson WD, Scott GM, Degli-Esposti MA: The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol Cell Biol 2007, 85: 46-54.
Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, Yokoyama WM: Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2001, 2: 951-956.
Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA: Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002, 169: 4279-4287.
Sjolin H, Robbins SH, Bessou G, Hidmark A, Tomasello E, Johansson M, Hall H, Charifi F, Karlsson Hedestam GB, Biron CA, Kärre K, Höglund P, Vivier E, Dalod M: DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. J Immunol 2006, 177: 2908-2916.
Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP: Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999, 17: 189-220.
Ghiringhelli F, Menard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L: CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 2005, 202: 1075-1085.
Shimizu J, Yamazaki S, Sakaguchi S: Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999, 163: 5211-5218.
Smyth MJ, Teng MW, Swann J, Kyparissoudis K, Godfrey DI, Hayakawa Y: CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 2006, 176: 1582-1587.
Gasteiger G, Hemmers S, Bos PD, Sun JC, Rudensky AY: IL-2-dependent adaptive control of NK cell homeostasis. J Exp Med 2013, 210: 1179-1187.
Gasteiger G, Hemmers S, Firth MA, Le Floc'h A, Huse M, Sun JC, Rudensky AY: IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells. J Exp Med 2013, 210: 1167-1178.
Powers C, DeFilippis V, Malouli D, Fruh K: Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 2008, 325: 333-359.
Noriega V, Redmann V, Gardner T, Tortorella D: Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 2012, 54: 140-151.
Snyder CM, Cho KS, Bonnett EL, Allan JE, Hill AB: Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog 2011, 7: e1002295.
Torti N, Walton SM, Brocker T, Rulicke T, Oxenius A: Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog 2011, 7: e1002313.
Lahl K, Mayer CT, Bopp T, Huehn J, Loddenkemper C, Eberl G, Wirnsberger G, Dornmair K, Geffers R, Schmitt E, Buer J, Sparwasser T: Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice. J Immunol 2009, 183: 5662-5672.
Loh J, Chu DT, O'Guin AK, Yokoyama WM, Virgin HW: Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol 2005, 79: 661-667.
Sumaria N, van Dommelen SL, Andoniou CE, Smyth MJ, Scalzo AA, Degli-Esposti MA: The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity. Immunol Cell Biol 2009, 87: 559-566.
Dorner BG, Smith HR, French AR, Kim S, Poursine-Laurent J, Beckman DL, Pingel JT, Kroczek RA, Yokoyama WM: Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection. J Immunol 2004, 172: 3119-3131.
Orange JS, Biron CA: An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 1996, 156: 1138-1142.
Mitrovic M, Arapovic J, Jordan S, Fodil-Cornu N, Ebert S, Vidal SM, Krmpotic A, Reddehase MJ, Jonjic S: The NK cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8(+) T-cell response. J Virol 2012, 86: 2165-2175.
Fogel LA, Sun MM, Geurs TL, Carayannopoulos LN, French AR: Markers of nonselective and specific NK cell activation. J Immunol 2013, 190: 6269-6276.
Ahmed A: Antiviral treatment of cytomegalovirus infection. Infect Disord Drug Targets 2011, 11: 475-503.
Cabrera G, Burzyn D, Mundinano J, Courreges MC, Camicia G, Lorenzo D, Costa H, Ross SR, Nepomnaschy I, Piazzon I: Early increases in superantigen-specific Foxp3+ regulatory T cells during mouse mammary tumor virus infection. J Virol 2008, 82: 7422-7431.
Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF: Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004, 78: 2454-2459.
Haeryfar SM, DiPaolo RJ, Tscharke DC, Bennink JR, Yewdell JW: Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities. J Immunol 2005, 174: 3344-3351.
Fernandez MA, Yu U, Zhang G, White R, Sparwasser T, Alexander SI, Jones CA: Treg depletion attenuates the severity of skin disease from ganglionic spread after HSV-2 flank infection. Virology 2013, 447: 9-20.
Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, Kiely N, Prince HE, Ndhlovu LC, Nixon DF, Kamel HT, Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ: Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 2009, 119: 3266-3277.
Haque A, Best SE, Amante FH, Mustafah S, Desbarrieres L, de Labastida F, Sparwasser T, Hill GR, Engwerda CR: CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog 2010, 6: e1001221.
Rowe JH, Ertelt JM, Way SS: Foxp3(+) regulatory T cells, immune stimulation and host defence against infection. Immunology 2012, 136: 1-10.
Baumgart M, Tompkins F, Leng J, Hesse M: Naturally occurring CD4+Foxp3+ regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J Immunol 2006, 176: 5374-5387.
Dunham RM, Thapa M, Velazquez VM, Elrod EJ, Denning TL, Pulendran B, Grakoui A: Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid. J Immunol 2013, 190: 2009-2016.
Sungur CM, Tang-Feldman YJ, Ames E, Alvarez M, Chen M, Longo DL, Pomeroy C, Murphy WJ: Murine natural killer cell licensing and regulation by T regulatory cells in viral responses. Proc Natl Acad Sci U S A 2013, 110: 7401-7406.
Mayer CTGP, Kühl AA, Stüve P, Hegemann M, Berod L, Gershwin ME, Sparwasser T: Few Foxp3+ regulatory T cells are sufficient to protect adult mice from lethal autoimmunity. Eur J Immunol 2014. In press edition
Fulton RB, Meyerholz DK, Varga SM: Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J Immunol 2010, 185: 2382-2392.
Lee DC, Harker JA, Tregoning JS, Atabani SF, Johansson C, Schwarze J, Openshaw PJ: CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J Virol 2010, 84: 8790-8798.
Sitrin J, Ring A, Garcia KC, Benoist C, Mathis D: Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2. J Exp Med 2013, 210: 1153-1165.
Mitrovic M, Arapovic J, Traven L, Krmpotic A, Jonjic S: Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infection. Med Microbiol Immunol 2012, 201: 487-495.
Andoniou CE, Andrews DM, Degli-Esposti MA: Natural killer cells in viral infection: more than just killers. Immunol Rev 2006, 214: 239-250.
Robbins SH, Bessou G, Cornillon A, Zucchini N, Rupp B, Ruzsics Z, Sacher T, Tomasello E, Vivier E, Koszinowski UH, Dalod M: Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog 2007, 3: e123.
Arens R, Wang P, Sidney J, Loewendorf A, Sette A, Schoenberger SP, Peters B, Benedict CA: Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response. J Immunol 2008, 180: 6472-6476.
Andoniou CE, van Dommelen SL, Voigt V, Andrews DM, Brizard G, Asselin-Paturel C, Delale T, Stacey KJ, Trinchieri G, Degli-Esposti MA: Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 2005, 6: 1011-1019.
Jeitziner SM, Walton SM, Torti N, Oxenius A: Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection. Eur J Immunol 2013, 43: 2886-2895.
Jost NH: Regulatory T cells and T cell-derived IL-10 interfere with effective anti-cytomegalovirus immune response. Immunol and Cell Biol 2014. In press edition
Wagner M, Jonjic S, Koszinowski UH, Messerle M: Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J Virol 1999, 73: 7056-7060.
May T, Hauser H, Wirth D: Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization. Nucleic Acids Res 2004, 32: 5529-5538.
Brune W, Hengel H, Koszinowski UH: A mouse model for cytomegalovirus infection. Curr Protoc Immunol 2001, Chapter 19: Unit 19 17.
We would like to acknowledge the Hannover Biomedical Research School (HBRS, DFG GSC108) and the “StrucMed” program for supporting ML. Additionally, we thank Prof. Dr. Martin Messerle, Dr. Kirsten Keyser and Karen Wagner for advice on the work with MCMV. Furthermore we express our acknowledgment to Dr. Tobias May for providing the Dox-MEF cell line. We are very thankful to Melanie Gohmert, Maike Hegemann, Friederike Kruse, Maxine Swallow and Martina Thiele for expert technical assistance and mouse management. For critical reading, we thank Aline Sandouk. Finally, we would like to acknowledge our funding source the Sonderforschungsbereich 900 (SFB-900) and the HiLF grant awarded by the Hannover Medical School for providing the resources for supporting this study.
The authors declare they have no competing interests.
ML drafted the paper and was responsible for the major experimental work carried out in the manuscript. GS helped performing experiments and analysis for this manuscript, FP and TS conceived the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
Electronic supplementary material
Additional file 1: Figure S1: MCMV infection induces increase in Treg frequency and number in infected Treg depleted mice. Total number of FoxP3+CD4+ Tregs 40 h (A), 3 days (B) and 7 days p.i. (C) and DT treatment. Infected wt mice showed increased Treg frequencies irrespective of DT treatment (D). Data shown is representative of at least 2 experiments, whereas data on day 3 p.i. is pooled from two individual experiments out of three, significance was determined by two tailed, unpaired Student’s t test. (*) p < 0,05. (PDF 14 KB)
Additional file 2: Figure S2: Selective depletion of Tregs in DEREG mice. (A) Gating Strategy for examining Treg frequencies. (B) Representative FACS plots showing the efficiency of Treg depletion in DEREG mice at 40 h, day 3 and day 7 p.i. Also included is a representative FACS plot showing undepleted control mice. Data shown is representative of two experiments with 2-4 mice per group. (PDF 408 KB)
Additional file 3: Figure S3: Activation and IFN-γ production by NK-Ly49H+ cells in Treg depleted mice. (A) Shows activation with regard to CD69 expression on Ly49H+NK1.1+ cells upon infection during Treg depletion. Data shown is representative of at least two experiments with 3-4 mice per group. (B) Expression of early activation marker CD69 on NK cells of infected mice is clearly reduced on day 7 in comparison to 40 h and 3 days p.i. But the results support the observation that Treg depletion under homeostatic conditions leads to higher NK cell activation. Data shown is representative of two experiments with 2-4 mice per group. (C) PMA/Ionomycin restimulation assay for splenic NK cell IFN-γ production showed similar results as IL-2 restimulation but with higher unspecific ex vivo activation. Groups consisted of 3-5 mice and significance was determined by two tailed, unpaired Student’s t test. (***) p < 0,0001; (ns) not significantly different. (PDF 21 KB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Lindenberg, M., Solmaz, G., Puttur, F. et al. Mouse Cytomegalovirus infection overrules T regulatory cell suppression on natural killer cells. Virol J 11, 145 (2014). https://doi.org/10.1186/1743-422X-11-145
- Mouse cytomegalovirus
- NK cells